Substance / Medication

Ticarcillin

Overview

Active Ingredient
ticarcillin
RxNorm CUI
10591

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

97 trials linked to this intervention

97
Total Trials
26
Recruiting
8
With Results

Research Evidence

Published studies and systematic reviews

Sort:
A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.
Naseem Anjum, Hussain Yasser, Ahmad Bashir et al. · J Pak Med Assoc · 2011
PMID: 22368896RCT
Comparison of ticarcillin and piperacillin in Kenney's semen extender.
Dietz J P, Sertich P L, Boston R C et al. · Theriogenology · 2007
PMID: 17706757ObservationalFull text (PMC)
Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients.
Yellin Albert E, Johnson Jeffrey, Higareda Iliana et al. · Am J Surg · 2007
PMID: 17693284Observational
Administration of ticarcillin in combination with clavulanic acid intravenously and intrauterinely to clinically normal oestrous mares.
Van Camp S D, Papich M G, Whitacre M D · J Vet Pharmacol Ther · 2000
PMID: 11168915Observational
Continuous infusion meropenem and ticarcillin-clavulanate in pediatric cystic fibrosis patients.
Zobell Jeffery T, Ferdinand Christina, Young David C · Pediatr Pulmonol · 2014
PMID: 23775821Case Report
[Management of ENT diseases complications using ticarcillin clavulanate].
Eliseev O V, Balandin A V, Dimova A D · Vestn Otorinolaringol · 2004
PMID: 15134082Case Report
Advancing Antibiotic Residue Analysis: LC-MS/MS Methodology for Ticarcillin Degradation Products in Tomato Leaves.
Hakeem Muhammad K, Elangovan Sampathkumar, Rafi Mohammed et al. · Antibiotics (Basel) · 2024
PMID: 38391519OtherFull text (PMC)
Ticarcillin degradation product thiophene acetic acid is a novel auxin analog that promotes organogenesis in tomato.
George Suja, Rafi Mohammed, Aldarmaki Maitha et al. · Front Plant Sci · 2023
PMID: 37731982OtherFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ticarcillin (substance)
SNOMED CT
372577006
UMLS CUI
C0040193
RxNorm CUI
10591

Clinical Data

This intervention maps to 7 entities in the Healos knowledge graph.

7
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
97
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.